Derma Sciences, Inc. is a specialty medical device / pharmaceutical company focused on wound care.

Derma Sciences, Inc. is a specialty medical device / pharmaceutical company focused on wound care. As fully integrated manufacturer, marketer and supplier of a complete line of products for wound and skin care, we have full lines of products in the following categories: Advanced Wound Care, Traditional Wound Care, Burn Care, Skin Care and Bathing, Specialty Securement and Closure Devices, and First Aid. With two wholly owned and operated manufacturing facilities in Toronto and China, we also offer exceptional contract manufacturing services for OEM or private label products.

Our company’s focus is on developing and driving sales of novel advanced wound care products, along with continuing to drive our contract manufacturing business. Regarding advanced wound care, we have built an innovative line of products that has seen quick adoption by clinicians. The line includes our market leading MEDIHONEY® line of Active Leptospermum Honey dressings, XTRASORB® Super Absorbent Polymer Dressings for highly exuding wounds, BIOGUARD® Barrier Dressings for prophylactic infection prevention, ALGICELL® Ag for wounds with high bioburden, and TCC-EZ® — a gold standard total contact casting system for the management of diabetic foot ulcers.

With regard to contract manufacturing, through various acquisitions over the past six years, Derma Sciences has built a strong business with broad capabilities. This strength has helped us to accelerate the growth of our private label and contract manufacturing partnerships with some of the largest distributors and wound / skin care products providers in the world. The recent addition of a First Aid line has provided strong growth to our manufacturing business, as well as the ability to take the rest of our line into the retail channel.

As we look to the future, our goal is to increase our leadership position in the growing field of wound and skin care, leveraging both our key brands as well as our manufacturing capabilities, while continuing to bring next-generation products and technologies to the market.